Application no. and date | 17841107.0 (espacenet) (Federated) (European Patent Register), 20170818 | Patent/reg. no. and date | DK/EP 3500299, 20231213 | Publication date | 20190626 | Priority no. and date | WO PCT/CN2016/096082, 20160819 | EP pub. no. and date |
EP 3500299 20190626 | Effective date | | Applicant/owner | BeiGene Switzerland GmbH, Aeschengraben 27
4051 Basel, CH | Applicant ref. no. | V470057DK00 | Inventor | SONG, Jing, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, LI, Kang, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, ZHANG, Tong, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, WANG, Lai, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, LUO, Lusong, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, WEI, Min, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, HU, Nan, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, WANG, Zhiwei, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN, GUO, Yunhang, No.30 Science Park Road Zhongguancun Life Science Park Changping
Beijing 102206, CN | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4162 (2006.01) , A61K 31/519 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | Kombination af zanubrutinib med et anti-CD20- eller et anti-PD-1-antistof til anvendelse i behandling af cancer | Int. application no. | CN2017098023 | Int. publication no. | WO2018033135 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|